Journal
NEUROBIOLOGY OF DISEASE
Volume 109, Issue -, Pages 219-225Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.nbd.2017.03.007
Keywords
Alpha-synuclein; Axonal transport; Exosome; Fibrils; Parkinson's disease; Prion; Spread; Tunneling nanotube; Unconventional secretion
Categories
Funding
- NIH [R35NS097263]
- Stanford Bio-X Interdisciplinary Initiatives Program
- HHMI Fellowship
- Stanford Graduate Fellowship
- NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R35NS097263] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Intra-neuronal protein aggregates made of fibrillar alpha-synuclein (alpha-syn) are the hallmark of Parkinson's disease (PD). With time, these aggregates spread through the brain following axonal projections. Understanding the mechanism of this spread is central to the study of the progressive nature of PD. Here we review data relevant to the uptake, transport and release of alpha-syn fibrils. We summarize several cell surface receptors that regulate the uptake of alpha-syn fibrils by neurons. The aggregates are then transported along axons, both in the anterograde and retrograde direction. The kinetics of transport suggests that they are part of the slow component b of axonal transport. Recent findings indicate that aggregated alpha-syn is secreted by neurons by non-canonical pathways that may implicate various molecular chaperones including USP19 and the DnaJ/Hsc70 complex. Additionally, alpha-syn fibrils may also be released and transmitted from neuron-to-neuron via exosomes and tunneling nano tubes. Understanding these different mechanisms and molecular players underlying alpha-syn spread is crucial for the development of therapies that could halt the progression of alpha-syn-related degenerative diseases. (C) 2017 The Authors. Published by Elsevier Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available